Alembic Pharma gets tentative USFDA nod for breast cancer drug

The tentative approval by the US Food Drug Administration (USFDA) was for Ribociclib tablets of strength 200 mg, Alembic Pharmaceuticals said in a regulatory filing.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *